[word=his | lemma=its | tag=JJ] □?
[word=his | lemma=its | tag=JJ] [□]?
[word=his | lemma=its | tag=JJ] (□ □)?
" " Of course - - how stupid of me l " he said , with a little loud laugh . The one-time $ 2.5 billion seller went on the market in 1999 and was taken by 20 million people when available to consumers.Carol Ernst alleges Vioxx triggered her husband 's death in his sleep just one month shy of their first wedding anniversary . " Interpretation " of the built environment that they're seeing is still the missing link for most people - - and this interpretation should be social as well as architectural . " They did n't say she did , either , " said Horn.The back-and-forth was one of several testy , rapid-fire exchanges in morning testimony , which at one point prompted the court stenographer to ask Superior Court Judge Carol E. Higbee to stop Tyberg and Horn from talking at the same time.Humeston , 60 , of Boise , Idaho , is one of about 6,500 former Vioxx users suing Merck over the drug , which it pulled off the market in September 2004 after long-term use was linked to increased risk of heart attacks and strokes.Horn also questioned Tyberg about his claim that stress from an ongoing probe of Humeston by U.S. Postal Service investigators helped trigger the heart attack . His lawyer was to give his summation to the jury Tuesday , after which jurors will begin deliberations.The closing arguments capped a seven-week trial focusing on the troubled painkiller and its alleged role in Humeston 's heart attack.Its outcome has high stakes for Merck , which lost the first product liability trial over Vioxx and could face tens of thousands more lawsuits.Speaking in a hushed courtroom packed with plaintiff 's lawyers , Wall Street analysts and reporters , Sullivan led off by showing jurors a slide presentation noting the conclusions of the U.S. Food and Drug Administration , which said earlier this year that Vioxx and other so-called Cox-2 inhibitors have no risks of heart attack and stroke in short-term use .